2013

  • Malda, J.; Visser, J.; Melchels, F.P.W.; Jungst, T.; Hennink, W.E.; Dhert, W.J.A.; Groll, J.; Hutmacher, D.W. / 25th anniversary article: Engineering hydrogels for biofabrication. In: Advanced materials, Vol. 25, No. 36, 2013, p. 5011-5028.
     
  • de Raad, M.; Kooijmans, S.A.A.; Teunissen, E.A.; Mastrobattista, E. / A Solid-Phase Platform for Combinatorial and Scarless Multipart Gene Assembly. In: ACS Synth Biol, Vol. 2, 2013, p. 316-326.
     
  • Bloem, E.; Meems, H.; van den Biggelaar, M.; Mertens, K.; Meijer, A.B. / A3 domain region 1803-1818 contributes to the stability of activated factor VIII and includes a binding site for activated factor IX. In: Journal of Biological Chemistry, Vol. 288, No. 36, 2013, p. 26105-11.
     
  • van Noort, J.M.; Bsibsi, M.; Nacken, P.J.; Gerritsen, W.H.; Amor, S.; Holtman, I.R.; Boddeke, E.; van Ark, I.; Leusink-Muis, A.; Folkerts, G.; Hennink, W.E.; Amidi, M. / Activation of an immune-regulatory macrophage response and inhibition of lung inflammation in a mouse model of COPD using heat-shock protein alpha B-crystallin-loaded PLGA microparticles. In: Biomaterials, Vol. 34, No. 3, 2013, p. 831-40.
     
  • Mastrobattista, E. / Advanced drug delivery in motion.In: International Journal of Pharmaceutics, Vol. 454, No. 1, 2013, p. 517-20.
     
  • Oerlemans, C.; Seevinck, P.R.; van de Maat, G.H.; Boulkhrif, H.; Bakker, C.J.G.; Hennink, W.E.; Nijsen, J.F.W / Alginate-lanthanide microspheres for MRI-guided embolotherapy. In: Acta Biomaterialia, Vol. 9, No. 1, 2013, p. 4681-4687.
     
  • Wang, J.W.; Bouwens, E.A.M.; Pintao, M.C.; Voorberg, J.; Safdar, H.; Valentijn, K.M.; de Boer, H.C.; Mertens, K.; Reitsma, P.H.; Eikenboom, J. / Analysis of the storage and secretion of von Willebrand factor in blood outgrowth endothelial cells derived from patients with von Willebrand disease. In: Blood, Vol. 121, No. 14, 2013, p. 2762-72.
     
  • Sauerborn, M.; van Beers, M.M.C.; Jiskoot, W.; Kijanka, G.M.; Boon, L; Schellekens, H.; Brinks, V. / Antibody response against Betaferon(R) in immune tolerant mice: involvement of marginal zone B-cells and CD4+ T-cells and apparent lack of immunological memory. In: Journal of Clinical Immunology, Vol. 33, No. 1, 2013, p. 255-63.
     
  • Mastrobattista, E. / Artificial microbes to fight cancer. In: Nanomedicine (Lond), Vol. 8, No. 1, 2013, p. 5-7.
     
  • van den Hoven, JM; Nemes, R.; Metselaar, J.M.; Nuijen, B.; Beijnen, J.H.; Storm, G.; Szebeni, J. / Complement activation by PEGylated liposomes containing prednisolone. In: European Journal of Pharmaceutical Sciences, Vol. 49, No. 2, 2013, p. 265-71.
     
  • Novo, L.; van Gaal, E.V.B.; Mastrobattista, E.; van Nostrum, C.F.; Hennink, W.E. / Decationized crosslinked polyplexes for redox-triggered gene delivery. In: Journal of Controlled Release, Vol. 169, No. 3, 2013, p. 246-56.
     
  • Polychniatis, T.; Hage, J.; Jansen, R.L.; Bouwers, E.; Visser, J. / Detecting Cross-language Dependencies Generically. Proceedings of the 17th European Conference on Software Maintenance and Reengineering (CSMR). 2013.
     
  • Meijerman, I.; Storm, G.; Moret, E.E.; Koster, A.S. / Development and student evaluation of an inquiry-based elective course on drug discovery and preclinical drug development. In: Currents in Pharmacy Teaching and Learning, Vol. 5, 2013, p. 14-22.
     
  • Ebbers, H.C.; Al-Temimi, E.; Moors, E.H.M.; Mantel-Teeuwisse, A.K.; Schellekens, H.; Leufkens, H.G.M. / Differences between post-authorization adverse drug reactions of biopharmaceuticals and small molecules. In: BioDrugs, Vol. 27, No. 2, 2013, p. 167-174.
     
  • Castro-Nunez, L.; Bloem, E.; Boon-Spijker, M.G.; van der Zwaan, C.; van den Biggelaar, M.; Mertens, K.; Meijer, A.B. / Distinct roles of Ser-764 and Lys-773 at the N terminus of von Willebrand factor in complex assembly with coagulation factor VIII. In: Journal of Biological Chemistry, Vol. 288, No. 1, 2013, p. 393-400.
     
  • Petit, A.; Muller, B.; Meijboom, R.; Bruin, P.; van de Manakker, F.; Versluijs-Helder, M.; de Leede, L.G.; Doornbos, A.; Landin, M.; Hennink, W.E.; Vermonden, T. / Effect of polymer composition on rheological and degradation properties of temperature-responsive gelling systems composed of acyl-capped PCLA-PEG-PCLA. In: Biomacromolecules, Vol. 14, No. 9, 2013, p. 3172-82.
     
  • Kijanka, G.; Jiskoot, W.; Schellekens, H.; Brinks, V. / Effect of treatment regimen on the immunogenicity of human interferon Beta in immune tolerant mice. In: Pharmaceutical Research, Vol. 30, No. 6, 2013, p. 1553-60.
     
  • Oerlemans, C.; Deckers, R.H.R.; Storm, G.; Hennink, W.E.; Nijsen, J.F.W / Evidence for a new mechanism behind HIFU-triggered release from liposomes. In: Journal of Controlled Release, Vol. 168, No. 3, 2013, p. 327-33.
     
  • Bloem, E.; van den Biggelaar, M.; Wroblewska, A.; Voorberg, J.; Faber, J.H.; Kjalke, M.; Stennicke, H.R.; Mertens, K.; Meijer, A.B. / Factor VIII C1 domain spikes 2092-2093 and 2158-2159 comprise regions that modulate cofactor function and cellular uptake. In: Journal of Biological Chemistry, Vol. 288, No. 41, 2013, p. 29670-9.
     
  • Eggenhuisen, T.M.; Munnik, P.; Talsma, H.; de Jongh, P.E.; de Jong, K.P. / Freeze-drying for controlled nanoparticle distribution in Co/SiO 2 Fischer–Tropsch catalysts. In: Journal of catalysis, Vol. 297, 2013, p. 306-313.
     
  • Feijen, J.; Hennink, W.E.; Zhong, Z. / From innovative polymers to advanced nanomedicine: key challenges, recent progress and future perspectives: the second Symposium on Innovative Polymers for Controlled Delivery Suzhou, China, 11-14 September 2012. In: Nanomedicine (Lond), Vol. 8, No. 2, 2013, p. 177-80.
     
  • Schuurman, Wouter; Levett, Peter A; Pot, Michiel W; van Weeren, Paul René; Dhert, Wouter J A; Hutmacher, Dietmar W; Melchels, Ferry P W; Klein, Travis J; Malda, Jos / Gelatin-methacrylamide hydrogels as potential biomaterials for fabrication of tissue-engineered cartilage constructs. In: Macromolecular Bioscience, Vol. 13, No. 5, 2013, p. 551-561.
     
  • Allijn, I.E.; Leong, W.; Tang, J.; Gianella, A.; Mieszawska, A.J.; Fay, F.; Ma, G.; Russell, S.; Callo, C.B.; Gordon, R.E.; Korkmaz, E.K.; Post, J.A.; Zhao, Y.; Gerritsen, H.C.; Thran, A.; Proksa, R.; Daerr, H.; Storm, G.; Fuster, V.; Fisher, E.A.; Fayad, Z.A.; Mulder, W.J.; Cormode, D.P. / Gold nanocrystal labeling allows low-density lipo. In: ACS nano, Vol. 7, No. 11, 2013, p. 9761-70.
     
  • Guichelaar, T.; Emmelot, M.E.; Rozemuller, H.; Martini, B.; Groen, R.W.J.; Storm, G.; Lokhorst, H.M.; Martens, A.C.M.; Mutis, T. / Human regulatory T cells do not suppress the antitumor immunity in the bone marrow: a role for bone marrow stromal cells in neutralizing regulatory T cells. In: Clinical Cancer Research, Vol. 19, No. 6, 2013, p. 1467-1475.
     
  • Torosantucci, R.; Sharov, V.S.; van Beers, M.M.C.; Brinks, V.; Schoneich, C.; Jiskoot, W. / Identification of oxidation sites and covalent cross-links in metal catalyzed oxidized interferon Beta-1a: potential implications for protein aggregation and immunogenicity. In: Molecular pharmaceutics, Vol. 10, 2013, p. 2311-2322.
     
  • Brinks, V. / Immunogenicity of biosimilar monoclonal antibodies. In: Generics and Biosomilars Initiative Journal, Vol. 2, No. 4, 2013.
     
  • van Meer, P.J.K.; Kooijman, M.; Brinks, V.; Gispen-de Wied, C.C.; Silva-Lima, B.; Moors, E.H.M.; Schellekens, H. / Immunogenicity of mAbs in non-human primates during nonclinical safety assessment. In: MAbs, Vol. 5, No. 5, 2013, p. 810-816.
     
  • Sandker, M.J.; Petit, A.; Redout, E.; Siebelt, M; Müller, B.; Bruin, P.; Meyboom, R.; Vermonden, T.; Hennink, W.E.; Weinans, H.H. / In situ forming acyl-capped PCLA-PEG-PCLA triblock copolymer based hydrogels. In: Biomaterials, Vol. 34, No. 32, 2013, p. 8002-8011.
     
  • Rizzo, L.Y.; Golombek, S.K.; Mertens, M.E.; Pan, Y.; Laaf, D.; Broda, J.; Jayapaul, J.; Mockel, D.; Subr, V.; Hennink, W.E.; Storm, G.; Simon, U.; Jahnen-Dechent, W.; Kiessling, F.; Lammers, T. / In Vivo Nanotoxicity Testing using the Zebrafish Embryo Assay. In: J Mater Chem B Mater Biol Med, Vol. 1, 2013, p. 3918-3925.
     
  • van der Meel, R.; Oliveira, S.; Altintas, I.; Heukers, R.; Pieters, E.H.E.; van Bergen en Henegouwen, P.M.P.; Storm, G.; Hennink, W.E.; Kok, R.J.; Schiffelers, R.M. / Inhibition of tumor growth by targeted anti-EGFR/IGF-1R nanobullets depends on efficient blocking of cell survival pathways. In: Molecular pharmaceutics, Vol. 10, No. 10, 2013, p. 3717-27.
     
  • Matricardi, P.; Di Meo, C.; Coviello, T.; Hennink, W.E.; Alhaique, F. / Interpenetrating Polymer Networks polysaccharide hydrogels for drug delivery and tissue engineering. In: Advanced Drug Delivery Reviews, Vol. 65, No. 9, 2013, p. 1172-87.
     
  • Storm, G. / Interview with Gert Storm. In: Ther. Deliv. 4, 2013, p. 1493-1497.
     
  • Bult, W.; Kroeze, S.G.C.; Elschot, M.; Seevinck, P.R.; Beekman, F.J.; de Jong, H.W.A.M.; Uges, D.R.A.; Kosterink, J.G.W.; Luijten, P.R.; Hennink, W.E.; van het Schip, A.D.; Bosch, J.L.H.R.; Nijsen, J.F.W; Jans, J.J.M. / Intratumoral administration of holmium-166 acetylacetonate microspheres: antitumor efficacy and feasibility of multimodality imaging in renal cancer. In: PLoS ONE [E], Vol. 8, No. 1, 2013, p. e52178.
     
  • Talelli, M.; Oliveira, S.; Rijcken, C.J.F.; Pieters, E.H.E.; Etrych, T.; Ulbrich, K.; van Nostrum, R.C.; Storm, G.; Hennink, W.E.; Lammers, T. / Intrinsically active nanobody-modified polymeric micelles for tumor-targeted combination therapy. In: Biomaterials, Vol. 34, No. 4, 2013, p. 1255-60.
     
  • Fitzsimons, C.P.; van Hooijdonk, L.W.; Schouten, M.; Zalachoras, I.; Brinks, V.; Zheng, T.; Schouten, T.G.; Saaltink, D.; Dijkmans, T.F.; Steindler, D.A.; Verhaagen, J.; Verbeek, F.J.; Lucassen, P.J.; de Kloet, E.R.; Meijer, O.C.; Karst, H.; Joels, M.; Oitzl, M.S.; Vreugdenhil, E. / Knockdown of the glucocorticoid receptor alters functional integration of newborn neurons in the adult hippocampus and impairs fear-motivated behavior. In: Molecular Psychiatry, Vol. 18, No. 9, 2013, p. 993-1005.​
     
  • van der Meel, R.; Vehmeijer, L.J.; Kok, R.J.; Storm, G.; van Gaal, E.V.B. / Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status. In: Advanced Drug Delivery Reviews, Vol. 65, No. 10, 2013, p. 1284-98.
     
  • Hofkens, W.; Schelbergen, R.; Storm, G.; van der Berg, W.B.; van Lent, P.L.E.M. / Liposomal targeting of prednisolone phosphate to synovial lining macrophages during experimental arthritis inhibits M1 activation but does not favor M2 differentiation. In: PLoS ONE [E], Vol. 8, No. 2, 2013.
     
  • Knezevi, N.Z.; Ruiz-Hernandez, E.; Hennink, W.E.; Vallet-Regi, M. / Magnetic mesoporous silica-based core/shell nanoparticles for biomedical applications. In: RSC Advances, Vol. 3, 2013, p. 9584-9593.
     
  • Ebbers, H.C.; van Meer, P.J.K.; Moors, E.H.M.; Mantel-Teeuwisse, A.K.; Leufkens, H.G.M.; Schellekens, H. / Measures of biosimilarity in monoclonal antibodies in oncology: the case of bevacizumab. In: Drug Discovery Today, Vol. 18, No. 17/18, 2013, p. 872-879.
     
  • Samadi, N.; van Nostrum, C.F.; Vermonden, T.; Amidi, M.; Hennink, W.E. / Mechanistic studies on the degradation and protein release characteristics of poly(lactic-co-glycolic-co-hydroxymethylglycolic acid) nanospheres. In: Biomacromolecules, Vol. 14, No. 4, 2013, p. 1044-53.
     
  • Deddens, L.H.; van Tilborg, G.A.F.; van der Toorn, A.; van der Marel, K.; Paulis, L.E.; van Bloois, L.; Storm, G.; Strijkers, G.J.; Mulder, W.J.; de Vries, H.E.; Dijkhuizen, R.M. / MRI of icam-1 upregulation after stroke: the importance of choosing the appropriate target-specific particulate contrast agent. In: Molecular Imaging and Biology, Vol. 15, No. 4, 2013, p. 411-422.
     
  • Kunjachan, S.; Rychlik, B.; Storm, G.; Kiessling, F.; Lammers, T. / Multidrug resistance: Physiological principles and nanomedical solutions. In: Advanced Drug Delivery Reviews, Vol. 65, No. 13-14, 2013, p. 1852-65.
     
  • Altintas, I.; Heukers, R.; van der Meel, R.; Lacombe, M.; Amidi, M.; van Bergen en Henegouwen, P.M.P.; Hennink, W.E.; Schiffelers, R.M.; Kok, R.J. / Nanobody-albumin nanoparticles (NANAPs) for the delivery of a multikinase inhibitor 17864 to EGFR overexpressing tumor cells. In: Journal of Controlled Release, Vol. 165, No. 2, 2013, p. 110-118.
     
  • Akhter, S.; Ahmad, I.; Ahmad, M.Z.; Ramazani, F.; Singh, A.; Rahman, Z.; Ahmad, F.J.; Storm, G.; Kok, R.J. / Nanomedicines as cancer therapeutics: current status. In: Curr Cancer Drug Targets, Vol. 13, No. 4, 2013, p. 362-78.
     
  • Deckers, R.H.R.; Paradissis, A.; Oerlemans, C.; Talelli, M.A.; Storm, G.; Hennink, W.E.; Nijsen, J.F.W / New insights into the HIFU-triggered release from polymeric micelles. In: Langmuir, Vol. 29, No. 30, 2013, p. 9483-9490.
     
  • Kunjachan, S.; Gremse, F.; Theek, B.; Koczera, P.; Pola, R.; Pechar, M.; Etrych, T.; Ulbrich, K.; Storm, G.; Kiessling, F.; Lammers, T. / Noninvasive optical imaging of nanomedicine biodistribution. In: ACS nano, Vol. 7, No. 1, 2013, p. 252-62.
     
  • Cherng, J.Y.; Hou, T.Y.; Shih, M.F.; Talsma, H.; Hennink, W.E. / Polyurethane-based drug delivery systems. In: International Journal of Pharmaceutics, Vol. 450, No. 1-2, 2013, p. 145-62.
     
  • Brinks, V.; Weinbuch, D.; Baker, M.; Dean, Y.; Stas, P.; Kostense, S.; Rup, B.; Jiskoot, W. / Preclinical models used for immunogenicity prediction of therapeutic proteins. In: Pharmaceutical Research, Vol. 30, No. 7, 2013, p. 1719-28.
     
  • Teunissen, E.A.; de Raad, M.; Mastrobattista, E. / Production and biomedical applications of virus-like particles derived from polyomaviruses. In: Journal of Controlled Release, Vol. 172, No. 1, 2013, p. 305-21.
     
  • Harmsen, S,; Meijerman, I.; Maas-Bakker, R.F.M.; Beijnen, J.H.; Schellens, J.H.M. / PXR-mediated P-glycoprotein induction by small molecule tyrosine kinase inhibitors. In: European Journal of Pharmaceutical Sciences, Vol. 48, No. 4-5, 2013, p. 644-9.
     
  • Willemsz, T.A.; Nguyen, T.T.; Hooijmaijers, R.; Frijlink, H.W.; Vromans, H.; van der Voort Maarschalk, K. / Quantitative characterization of agglomerate abrasion in a tumbling blender by using the Stokes number approach. In: AAPS PharmSciTech, Vol. 14, No. 1, 2013, p. 183-8.
     
  • Rizzo, L.Y.; Theek, B.; Storm, G.; Kiessling, F.; Lammers, T. / Recent progress in nanomedicine: therapeutic, diagnostic and theranostic applications. In: Current Opinion in Biotechnology, Vol. 24, No. 6, 2013, p. 1159-66.
     
  • Alaarg, A.M.S.A.; Schiffelers, R.M.; van Solinge, W.W.; van Wijk, H.A. / Red blood cell vesiculation in hereditary hemolytic anemia. In: Frontiers in Physiology [E], Vol. 4, 2013, p. 365.
     
  • Liu, J.; Xu, Y.; Yang, Q.; Li, C.; Hennink, W.E.; Zhuo, R.; Jiang, X. / Reduction biodegradable brushed PDMAEMA derivatives synthesized by atom transfer radical polymerization and click chemistry for gene delivery. In: Acta Biomaterialia, Vol. 9, No. 8, 2013, p. 7758-66. 
     
  • Shi, Y.; van den Dungen, E.T.A.; Klumperman, B.; van Nostrum, C.F.; Hennink, W.E. / Reversible addition−fragmentation chain transfer synthesis of a micelle-forming, structure reversible thermosensitive diblock copolymer based on the N‑(2-hydroxy propyl)methacrylamide backbone. In: ACS macro letters, Vol. 2, 2013, p. 403-408.
     
  • Moss, A.C.; Brinks, V.; Carpenter, J.F. / Review article: immunogenicity of anti-TNF biologics in IBD - the role of patient, product and prescriber factors. In: Alimentary Pharmacology & Therapeutics, Vol. 38, 2013, p. 1188-1197.
     
  • Oude Blenke, E.; Mastrobattista, E.; Schiffelers, R.M. / Strategies for triggered drug release from tumor targeted liposomes. In: Expert Opinion on Drug Delivery, Vol. 10, No. 10, 2013, p. 1399-410.
     
  • Oliveira, S.; Heukers, R.; Sornkom, J.; Kok, R.J.; van Bergen en Henegouwen, P.M.P. / Targeting tumors with nanobodies for cancer imaging and therapy. In: Journal of Controlled Release, Vol. 172, No. 3, 2013, p. 607-617.
     
  • Bouvy, J.C.; Ebbers, H.C.; Schellekens, H.; Koopmanschap, M.A. / The cost-effectiveness of periodic safety update reports for biologicals in Europe. In: Clinical Pharmacology & Therapeutics, Vol. 93, No. 5, 2013, p. 433-42.
     
  • Smits, E.A.; Smits, C.J.; Vromans, H. / The development of a method to quantify encapsulated and free prednisolone phosphate in liposomal formulations. In: Journal of Pharmaceutical and Biomedical Analysis, Vol. 75, 2013, p. 47-54.
     
  • Samadi, N.; Abbadessa, A.; Di Stefano, A.; van Nostrum, C.F.; Vermonden, T.; Rahimian, S.; Teunissen, E.A.; van Steenbergen, M.J.; Amidi, M.; Hennink, W.E. / The effect of lauryl capping group on protein release and degradation of poly(d,l-lactic-co-glycolic acid) particles. In: Journal of Controlled Release, Vol. 172, No. 2, 2013, p. 436-43.
     
  • Schellekens, H.; Hennink, W.E.; Brinks, V. / The immunogenicity of polyethylene glycol: facts and fiction. In: Pharmaceutical Research, Vol. 30, No. 7, 2013, p. 1729-34.
     
  • Kooijman, M.; van Meer, P.J.K.; Gispen-de Wied, C.C.; Moors, E.H.M.; Hekkert, M.P.; Schellekens, H. / The risk-based approach to ATMP development - Generally accepted by regulators but infrequently used by companies. In: Regulatory Toxicology and Pharmacology, Vol. 67, No. 2, 2013, p. 221-225.
     
  • Ebbers, H.C.; Mantel-Teeuwisse, A.K.; Sayed-Tabatabaei, F.A.; Moors, E.H.M.; Schellekens, H.; Leufkens, H.G.M. / The role of Periodic Safety Update Reports in the safety management of biopharmaceuticals. In: European Journal of Clinical Pharmacology, Vol. 69, No. 2, 2013, p. 217-226.
     
  • van Meer, P.J.K.; Kooijman, M.; van der Laan, J.W.; Moors, E.H.M.; Schellekens, H. / The value of non-human primates in the development of monoclonal antibodies. In: Nature Biotechnology, Vol. 31, No. 10, 2013, p. 882-3.
     
  • Oostvogels, R.; Minnema, M.C.; van Elk, M.; Spaapen, R.M.; te Raa, G.D.; Giovannone, B.; Buijs, A.; van Baarle, D.; Kater, A.P.; Griffioen, M.; Spierings, E.; Lokhorst, H.M.; Mutis, T. / Towards effective and safe immunotherapy after allogeneic stem cell transplantation: identification of hematopoietic-specific minor histocompatibility antigen UTA2-1. In: Leukemia, Vol. 27, No. 3, 2013, p. 642-649.
     
  • Crommelin, D.J.A.; Florence, A.T. / Towards more effective advanced drug delivery systems. In: International Journal of Pharmaceutics, Vol. 454, 2013, p. 496-511.
     
  • Yousefi, A.; Storm, G.; Schiffelers, R.M.; Mastrobattista, E. / Trends in polymeric delivery of nucleic acids to tumors. In: Journal of Controlled Release, Vol. 170, No. 2, 2013, p. 209-18.
     
  • Visser, Jetze; Melchels, Ferry P W; Dhert, Wouter J A; Malda, Jos / Weefsel uit de printer : de mogelijkheden van 3D-printen in de geneeskunde. In: Nederlands Tijdschrift voor Geneeskunde, Vol. 157, No. 52, 2013, p. A7043.
     
  • Shi, Y.; van Steenbergen, M.J.; Teunissen, E.A.; Novo, L.; Gradmann, S.; Baldus, M.; van Nostrum, C.F.; Hennink, W.E. / Π−Π Stacking increases the stability and loading capacity of thermosensitive polymeric micelles for chemotherapeutic drugs. In: Biomacromolecules, Vol. 14, No. 6, 2013, p. 1826-1837.
     
  • Visser, Jetze; Peters, Benjamin; Burger, Thijs J; Boomstra, Jelle; Dhert, Wouter J A; Melchels, Ferry P W; Malda, Jos / Biofabrication of multi-material anatomically shaped tissue constructs. In: Biofabrication, Vol. 5, No. 3, 09.2013, p. 035007.